Castle Creek Biosciences

About:

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

Website: https://castlecreekbio.com/

Twitter/X: CastleCreekBio

Top Investors: Fidelity, Valor Equity Partners, Horizon Technology Finance, Paragon Biosciences

Description:

Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States.

Total Funding Amount:

$309M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Exton, Pennsylvania, United States

Founded Date:

2015-01-01

Contact Email:

contact(AT)castlecreekpharma.com

Founders:

Jeff Aronin, Michael Derby

Number of Employees:

11-50

Last Funding Date:

2022-05-02

IPO Status:

Private

© 2025 bioDAO.ai